Moderna, Inc. earnings per share and revenue

MRNA earnings per share for the last quarter are -2.91 USD whereas the estimation was -2.68 USD which accounts for -8.57% surprise. Company revenue for the same period amounts to 966.00 M USD despite the estimated figure of 942.82 M USD. Estimated earnings per share for the next quarter are -3.03 USD, and revenue is expected to reach 166.70 M USD. Also watch annual changes over time to get a bigger picture of MRNA earnings per share and revenue dynamics.